UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2009
THE DOW CHEMICAL COMPANY
(Exact name of Registrant as specified in its charter)
Delaware | 1-3433 | 38-1285128 | ||
(State or other jurisdiction of incorporation) |
Commission File Number | (IRS Employer Identification No.) |
2030 Dow Center, Midland, Michigan | 48674 | |
(Address of principal executive offices) | (Zip code) |
(989) 636-1000
(Registrants telephone number, including area code)
N.A.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 | Entry into a Material Definitive Agreement |
On August 7, 2009, The Dow Chemical Company (the Company) completed the sale and issuance (the Offering) of $2.75 billion in aggregate principal amount of notes consisting of $1,250,000,000 principal amount of 4.85% Notes due 2012 (the Notes due 2012), $1,250,000,000 principal amount of 5.90% Notes due 2015 (the Notes due 2015) and $250,000,000 principal amount of Floating Rate Notes due 2011 (the Floating Rate Notes). The Offering was made pursuant to an Underwriting Agreement (the Underwriting Agreement) among the Company and the underwriters named therein.
The Offering has been registered under the Securities Act of 1933, as amended, pursuant to the Companys effective registration statement on Form S-3 (File No. 333-140859) (the Registration Statement) filed with the Securities and Exchange Commission (the Commission). The Underwriting Agreement is attached as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference into this Report and the Registration Statement.
The Company intends to use the proceeds from the Offering to repay a portion of the Companys borrowings under its Term Loan Agreement, dated as of September 8, 2008, and as amended by the First Amendment, dated as of March 4, 2009 (the Term Loan Agreement) and for refinancings, renewals, replacements and refundings of outstanding indebtedness. Certain of the Underwriters are affiliated with lenders under the Companys Term Loan Agreement. The forms of the Notes due 2012, the Notes due 2015 and the Floating Rate Notes are attached as Exhibits 4.1, 4.2, and 4.3, respectively, to this Current Report on Form 8-K and are incorporated by reference into this Report and the Companys Registration Statement.
Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
Exhibit No. |
Description | |
1.1 |
Underwriting Agreement, dated as of August 4, 2009 | |
4.1 |
Form of 4.85% Notes due 2012 | |
4.2 |
Form of 5.90% Notes due 2015 | |
4.3 |
Form of Floating Rate Notes due 2011 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 7, 2009
The Dow Chemical Company | ||
By: | /s/ William H. Weideman | |
Name: | William H. Weideman | |
Title: | Vice President and Controller |
EXHIBITS
Exhibit No. |
Description | |
1.1 |
Underwriting Agreement, dated as of August 4, 2009 | |
4.1 |
Form of 4.85% Notes due 2012 | |
4.2 |
Form of 5.90% Notes due 2015 | |
4.3 |
Form of Floating Rate Notes due 2011 |